www.g4media.ro/o-noua-metoda-pentru-dezvoltarea-va

Researchers at MIT have developed a technology for personalized cancer vaccines using harmless virus structures to enhance immune response. The method involves genetically modified bacteriophages that can carry specific tumor antigens, allowing the immune system to recognize and attack cancer cells. Experiments on mice showed that vaccines with higher antigen concentrations provided better protection against tumors. The technology can be tailored for different cancer types, aiming for individualized treatments. Although promising, further testing is needed before clinical application.